Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial.
Saved in:
| Title: | Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial. |
|---|---|
| Authors: | Rosenzwajg M; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France., Gherasim A; Centre de recherche clinique ALYATEC, Strasbourg, France., Dietsch F; Centre de recherche clinique ALYATEC, Strasbourg, France., Beck M; Centre de recherche clinique ALYATEC, Strasbourg, France., Domis N; Centre de recherche clinique ALYATEC, Strasbourg, France., Lorenzon R; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France., Chantran Y; Immunology Department, Saint Antoine Hospital, AP-HP, Paris, France., Bellier B; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France., Vicaut E; Unité de recherche clinique, Saint Louis/Lariboisière Hospitals, AP-HP, and Université Paris 7, Paris, France., Soria A; Dermatology and Allergy Department, Tenon Hospital, AP-HP, Paris., de Blay F; Centre de recherche clinique ALYATEC, Strasbourg, France., Klatzmann D; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France. Electronic address: david.klatzmann@sorbonne-universite.fr. |
| Source: | The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2025 Feb; Vol. 155 (2), pp. 650-655. Date of Electronic Publication: 2024 Nov 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39532189 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rosenzwajg+M%22">Rosenzwajg M</searchLink>; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR&#95;S 959, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gherasim+A%22">Gherasim A</searchLink>; Centre de recherche clinique ALYATEC, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Dietsch+F%22">Dietsch F</searchLink>; Centre de recherche clinique ALYATEC, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Beck+M%22">Beck M</searchLink>; Centre de recherche clinique ALYATEC, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Domis+N%22">Domis N</searchLink>; Centre de recherche clinique ALYATEC, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Lorenzon+R%22">Lorenzon R</searchLink>; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR&#95;S 959, Paris, France.<br /><searchLink fieldCode="AU" term="%22Chantran+Y%22">Chantran Y</searchLink>; Immunology Department, Saint Antoine Hospital, AP-HP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bellier+B%22">Bellier B</searchLink>; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR&#95;S 959, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vicaut+E%22">Vicaut E</searchLink>; Unité de recherche clinique, Saint Louis/Lariboisière Hospitals, AP-HP, and Université Paris 7, Paris, France.<br /><searchLink fieldCode="AU" term="%22Soria+A%22">Soria A</searchLink>; Dermatology and Allergy Department, Tenon Hospital, AP-HP, Paris.<br /><searchLink fieldCode="AU" term="%22de+Blay+F%22">de Blay F</searchLink>; Centre de recherche clinique ALYATEC, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Klatzmann+D%22">Klatzmann D</searchLink>; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR&#95;S 959, Paris, France. Electronic address: david.klatzmann@sorbonne-universite.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%221275002%22">The Journal of allergy and clinical immunology</searchLink> [J Allergy Clin Immunol] 2025 Feb; Vol. 155 (2), pp. 650-655. <i>Date of Electronic Publication: </i>2024 Nov 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>1275002 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6825 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200916749%22">00916749 </searchLink><i>NLM ISO Abbreviation: </i>J Allergy Clin Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39532189 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaci.2024.10.033 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 650 Titles: – TitleFull: Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rosenzwajg M – PersonEntity: Name: NameFull: Gherasim A – PersonEntity: Name: NameFull: Dietsch F – PersonEntity: Name: NameFull: Beck M – PersonEntity: Name: NameFull: Domis N – PersonEntity: Name: NameFull: Lorenzon R – PersonEntity: Name: NameFull: Chantran Y – PersonEntity: Name: NameFull: Bellier B – PersonEntity: Name: NameFull: Vicaut E – PersonEntity: Name: NameFull: Soria A – PersonEntity: Name: NameFull: de Blay F – PersonEntity: Name: NameFull: Klatzmann D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1097-6825 Numbering: – Type: volume Value: 155 – Type: issue Value: 2 Titles: – TitleFull: The Journal of allergy and clinical immunology Type: main |
| ResultId | 1 |